Test 1
Dietary Supplementsucrose : xylose = 10:1, sucrose 50 g + xylose 5 g + deionized water 95 g
NCT Number: NCT02654301
The present study determined the effect of Xylose consumption on postprandial hyperglycemia in normal (n=25) and hyperglycemic subjects (n=50).
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Not applicable
In this double-blind crossover designed study, Participants were randomly assigned to consume a sucrose drink (Control, sucrose 50g + deionized water 100g) or a sucrose drink additionally containing 5 g (Test 1, sucrose : xylose = 10:1), 3.33 g (Test 2, sucrose : xylose = 15:1) or 2.5 g (Test 3, sucrose : xylose = 20:1) of D-xylose with a week interval.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
sucrose : xylose = 10:1, sucrose 50 g + xylose 5 g + deionized water 95 g
sucrose : xylose = 15:1, sucrose 50 g + xylose 3.33 g + deionized water 96.67 g
sucrose : xylose = 20:1, sucrose 50 g + xylose 2.5 g + deionized water 97.5 g
sucrose 50 g + deionized water 100 g
Time frame: a week interval
Time frame: a week interval
Time frame: a week interval
Yonsei University
Other
Beneficial Effect of Xylose Consumption on Postprandial Hyperglycemia in Subjects With Normal Glucose Level and Impaired Fasting Glucose
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04499287
Diabetes Mellitus, Endocrine System Diseases
View Trial DetailsNCT04150926
Diabetes Mellitus, Endocrine System Diseases
Kuopio, Finland
View Trial DetailsNCT02896010
Diabetes Mellitus, Endocrine System Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT03836495
Energy Expenditure, Glucose Metabolism Disorders
Beirut, Lebanon
View Trial Details